The new SPAC intends to target businesses in the healthcare industry, particularly for North American or European companies in the life sciences and medical technology sectors, with a specific focus on small and large molecule therapeutics. Gardiner Healthcare is led by Chairman and CEO Marc F. Pelletier, CFO David P. Jenkins, and EVP and CDO Paul R. McGuirk.
Total SPAC deal count for 2021 year-to-date is now 610. This offering is expected to close on Monday, December 27.
Chardan is acting as book-running manager of the offering. B. Riley Securities, Inc. acted as qualified independent underwriter in the offering. Reed Smith LLP is serving as Issuer’s Counsel with Greenberg Traurig, LLP serving as Underwriter’s Counsel. BDO USA, LLP serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.